Community SpotlightSleep Apnea Eight Tips to Promote Healthy Sleep Habits for People with Down Syndrome Sometimes falling asleep and having a restful night isn’t as easy as we would hope.…adminFebruary 7, 2022
Press Release Natl. DS Organizations Launch Joint Effort to Change CMS Proposal for Alzheimer’s Treatments Date: 2/4/2022 Down Syndrome Affiliates in Action (DSAIA), Down Syndrome Medical Interest Group-USA (DSMIG-USA), GiGi's…adminFebruary 4, 2022
Community Spotlight Submit Comments to CMS so People with Down Syndrome Will Have Equal Access to Alzheimer’s Drugs ACTION NEEDED BY FEBRUARY 9, 2022: SUBMIT COMMENTS TO CMS SO PEOPLE WITH DOWN SYNDROME…adminFebruary 4, 2022
Research News Results From T21RS’s COVID-19 International Survey on Vaccination of Individuals With DS In a study led by the LuMind IDSC Foundation, the T21RS COVID-19 Initiative launched an…adminJanuary 26, 2022
Research Spotlight Results from T21RS’s COVID-19 International Survey on Vaccination of Individuals with DS January 26, 2022 In a study funded by the LuMind IDSC Foundation, the T21RS COVID-19 Initiative launched an…adminJanuary 26, 2022
Research News Five Recent Down Syndrome Research Data Articles to Stay Up to Date Recently, two institutions in the Down Syndrome Clinical Trials Network (DS-CTN) published five studies about Down syndrome-related…adminJanuary 25, 2022
Research Spotlight Five Recent Down Syndrome Research Data Articles to Stay Up to Date January 25, 2022 Recently, two institutions in the Down Syndrome Clinical Trials Network (DS-CTN) published five studies…adminJanuary 25, 2022
Research Spotlight Publication Illustrates Need for Therapies to Address Immune Aging in Down Syndrome Impaired immune function is a clear and growing threat to the health and well-being of…adminJanuary 20, 2022
Research News LuMind IDSC Statement on CMS Proposed Coverage for Anti-Amyloid AD Drugs During the past year, LuMind IDSC remained cautiously optimistic about treatment possibilities that the development…adminJanuary 12, 2022
Research Spotlight LuMind IDSC Statement on CMS Proposed Coverage for Anti-Amyloid AD Drugs January 12, 2022 During the past year, LuMind IDSC remained cautiously optimistic about treatment possibilities that…adminJanuary 12, 2022